Member Info for CanaryDwarf

https://youtu.be/cAO83EP4qEc

Next!!

Definitely a buy

Nice support shown here

Chart looking great. Nice bull flag formed over last few sessions- ready to move higher again IMO

Is remdesivir a substitute or complementary treatment when compared to Synairgen?

Reading that doc again- it could have been written this year.. (not sure of the month). So that’s 20+ companies testing at the time this doc was published- not back in June last year.

Interesting to read that back in June 2019 (after the May launch of MicroSalt), Salarius had already secured 3 customers and had more than 20 other companies ‘currently testing the product for potential inclusion in their products’.. this really has some very big potential. Looking forward to how this unfolds..
https://www.fundable.com/microsalt

‘A ‘not ‘B’

Agreed. A market cap of 11m is way too low for this company if you consider what is already in place as well as the near term potential/news flow.

The Frito-Lay link is just pure speculation, however it’s interesting to note that their consumer/ product strategy has focused upon low sodium snacks. This is a quote from back in 2008:
”The number one request from our consumers is for low-sodium versions of the products they love most," said Jaya Kumar, chief marketing officer, Frito-Lay North America. "While consumers request low-sodium versions of their favorite products, they aren't willing to compromise on taste.

Does anybody know who the North American distributor which was mentioned in the recent Salarius RNS? Could there be a link to Frito-lay by any chance? (subsidiary of PepsiCo). I hope so!

“The distributor is one of North America’s largest food wholesalers with distribution centers in the U.S. and Canada, shipping products to natural product superstores, conventional supermarket chains, independent retailers, business & industry, eCommerce retailers and the food service industry.”

Does anybody know what the client relationship is with PepsiCo?

I like the Salarius production process. It doesn’t lead to higher concentrations of other elements such as potassium in the final product. This is the case with alternative low sodium salt solutions.

Interesting COVID-19 report from the WHO, released earlier this week- oxygen concentrators in focus..
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200407-sitrep-78-covid-19.pdf

“The Operations Support and Logistics (OSL) unit at WHO is working to convene meetings with key stakeholders including oxygen, ventilator and concentrator manufacturers and producers of associated ancillary equipment. In addition to securing the appropriate equipment for those countries at most risk or most vulnerable, WHO and the PSCN is working with the World Bank and other UN agencies to ensure that the infrastructure, technical guidance and other operational guidance is available.”

https://time.com/5818547/ventilators-coronavirus/

Seems like doctors are moving towards the use of alternative oxygen delivery devices rather than the use of ventilators to treat Covid-19 patients. Good news for TEK/ Belluscura!

As NPX002 is an inhaler delivered version of Tranilast, surely this should be bringing Nuformix into focus?
http://www.chictr.org.cn/showprojen.aspx?proj=49738

Would be nice to get a 5pm RNS with an operational update...

I’m surprised that there hasn’t been a TR1 released by CPI. They were at 10.7% on 23rd Dec.

I have noticed a wave of above-average size buys appearing over the last 30mins. Let's hope this continues!